Kevin Koch
Tracked across 1 events · 6 articles · First seen Jun 01, 2026 · Last active Jun 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Kevin Koch, President and CEO of Edgewise Therapeutics, expressed belief that Laboratoires Servier is well-positioned to advance the muscular dystrophy program.
Jun 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Kevin Koch live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard